Recombinant multi-species ADSS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADSS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the adenylosuccinate synthase family of proteins. The encoded muscle-specific enzyme plays a role in the purine nucleotide cycle by catalyzing the first step in the conversion of inosine monophosphate (IMP) to adenosine monophosphate (AMP). Mutations in this gene may cause adolescent onset distal myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
The Alternative Names of target: ADSS1,ADSSL1,AMPSase 1,AdSS 1,Adenylosuccinate synthetase,Adenylosuccinate synthetase isozyme 1,Adenylosuccinate synthetase-like 1 (AdSSL1),Adss,Adss1,Adssl1,IMP--aspartate ligase 1,MPD5,basic isozyme,muscle isozyme (M-type adenylosuccinate synthetase)
Go
to ADSS1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP4362-Ag-1/ GM-Tg-hg-IP4362-Ag-2 | Human ADSS1 protein | Human |
| GM-Tg-rg-IP4362-Ag-1/ GM-Tg-rg-IP4362-Ag-2 | Rat ADSS1 protein | Rat |
| GM-Tg-mg-IP4362-Ag-1/ GM-Tg-mg-IP4362-Ag-2 | Mouse ADSS1 protein | Mouse |
| GM-Tg-cynog-IP4362-Ag-1/ GM-Tg-cynog-IP4362-Ag-2 | Cynomolgus/Rhesus macaque ADSS1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP4362-Ag-1/ GM-Tg-felg-IP4362-Ag-2 | Feline ADSS1 protein | Feline |
| GM-Tg-cang-IP4362-Ag-1/ GM-Tg-cang-IP4362-Ag-2 | Canine ADSS1 protein | Canine |
| GM-Tg-bovg-IP4362-Ag-1/ GM-Tg-bovg-IP4362-Ag-2 | Bovine ADSS1 protein | Bovine |
| GM-Tg-equg-IP4362-Ag-1/ GM-Tg-equg-IP4362-Ag-2 | Equine ADSS1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP4362-Ag-1/ GM-Tg-hg-IP4362-Ag-2;
GM-Tg-rg-IP4362-Ag-1/ GM-Tg-rg-IP4362-Ag-2;
GM-Tg-mg-IP4362-Ag-1/ GM-Tg-mg-IP4362-Ag-2; GM-Tg-cynog-IP4362-Ag-1/ GM-Tg-cynog-IP4362-Ag-2; GM-Tg-felg-IP4362-Ag-1/ GM-Tg-felg-IP4362-Ag-2; GM-Tg-cang-IP4362-Ag-1/ GM-Tg-cang-IP4362-Ag-2; GM-Tg-bovg-IP4362-Ag-1/ GM-Tg-bovg-IP4362-Ag-2; GM-Tg-equg-IP4362-Ag-1/ GM-Tg-equg-IP4362-Ag-2 |
| Products Name | ADSS1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ADSS1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADSS1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.